General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Ethicon EndoSurgery(MODEST), Medtronic(SIGNIFICANT), Persona(SIGNIFICANT), Mediflix(NONE), GI Dynamics(SIGNIFICANT), Keyron(NONE), Eli Lilly and Company(MODEST), Novo Nordisk Inc.(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: SE QHC, LLC(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Ethicon EndoSurgery(SIGNIFICANT), Pacira Pharmaceuticals, Inc(NONE), Medtronic(NONE)

View Full Disclosure